Resistance of KRAS Mutant Colon Cancers to Cetuximab May Be Overcome Through Antibody Engineering
Ajay Jain, Scott E. Strome(Northwestern Medicine Lake Forest Hospital), Nader Hanna(University of Maryland, Baltimore), Emmanuel Y. Mérigeon(Gliknik (United States)), Ling Cai(The University of Texas Southwestern Medical Center), Bhawna Poonia(Poornima University), Ravi Vyzasatya(University of Maryland, Baltimore), Harris G. Yfantis(University of Maryland, Baltimore), Henrik S. Olsen(Gliknik (United States)), David S. Block(Gliknik (United States)), Siaw‐Lin Chan(University of Maryland, Baltimore), H. Richard Alexander(Umeå University), Susan B. Kesmodel(University of Miami), Edward So(University of Maryland, Baltimore), William Twadell(University of Maryland, Baltimore)
Cited by 0
Related Papers
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k
Lactate Metabolism in Human Lung Tumors
|Cell|2017|1.3k
Multiple Cytokines and Acute Inflammation Raise Mouse Leptin Levels: Potential Role in Inflammatory Anorexia
|The Journal of Experimental Medicine|1997|797
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
|Proceedings of the National Academy of Sciences|2004|767